ABSTRACT
Purpose: Local recurrence predicts dismal prognosis in eyelid sebaceous carcinoma (SC). Recurrence predictors vary across studies. Accurate recurrence estimation is essential for individualized therapy in eyelid SC. This study aims to identify recurrence predictors and develop a nomogram for personalized prediction in eyelid SC. Methods: We conducted a multicenter retrospective cohort study. Chart reviews were performed in 418 consecutive patients with eyelid SC. All patients were followed up after their initial surgery. Multivariate Cox regression was used to explore the independent predictors of recurrence. A nomogram for recurrence prediction was developed and validated with bootstrap resampling. The predictive accuracy and discriminative ability were compared with the Tumor, Node, Metastasis (TNM) staging system. Results: Over a median of 60-month follow-up, 167 patients (40%) had local recurrence. The median time from diagnosis to recurrence was 14 months. The 1-year cumulative recurrence rate was 18%. Diagnostic delay (hazard ratio [HR] = 1.01, 95% confidence interval [CI] = 1.00-1.01, P = 0.001), orbital involvement (HR = 4.47, 95% CI = 3.04-6.58, P < 0.001), Ki67 (HR = 1.01, 95% CI = 1.00-1.02, P = 0.008) and initial surgery of Mohs micrographic surgery with intraoperative frozen section control (HR = 0.53, 95% CI = 0.35-0.80, P = 0.003) were independent influencing factors of recurrence. A nomogram integrating these four factors combined with pagetoid spread displayed satisfactory discriminative ability (C-index = 0.80-0.83; area under the curve [AUC] = 0.82-0.84), which compared favorably than TNM staging (all P < 0.05). Conclusions: The recurrence rate is high in eyelid SC. Early detection and primary resection with Mohs micrographic surgery are recommended in controlling recurrence. Patients with orbital involvement, high Ki67 expression, and pagetoid spread may require adjuvant measures. This nomogram offers more accurate recurrence estimates, aiding in therapeutic decision making.
Subject(s)
Adenocarcinoma, Sebaceous , Eyelid Neoplasms , Neoplasm Recurrence, Local , Nomograms , Sebaceous Gland Neoplasms , Humans , Male , Female , Retrospective Studies , Eyelid Neoplasms/pathology , Eyelid Neoplasms/diagnosis , Sebaceous Gland Neoplasms/pathology , Sebaceous Gland Neoplasms/diagnosis , Middle Aged , Aged , Adenocarcinoma, Sebaceous/pathology , Adenocarcinoma, Sebaceous/diagnosis , Follow-Up Studies , Neoplasm Staging , Aged, 80 and over , Adult , PrognosisABSTRACT
PURPOSE: To report the outcomes of platinum-based neoadjuvant chemotherapy (NACT) for eyelid and periocular sebaceous gland carcinoma (eSGC). METHODS: Retrospective study of 25 patients. RESULTS: The mean age at presentation of eSGC was 59 years. The mean tumor basal diameter was 46 mm. By the 8th edition of AJCC classification, tumors belonged T2 (n = 2, 8%), T3 (n = 6, 24%), and T4 (n = 17, 68%); N1 (n = 12,48%); and M1 (n = 1, 4%). NACT with 5-fluorouracil (5-FU) and cisplatin/carboplatin was administered in 21 (84%)/4 (16%) patients, respectively. The mean number of cycles of neoadjuvant systemic chemotherapy per patient was 2 (median, 3). The mean percentage reduction of tumor basal volume after neoadjuvant chemotherapy was 65% (median, 60%). After NACT, 12 (48%) patients underwent surgical treatment, 6 (12%) patients underwent EBRT, and 4 (8%) underwent adjuvant chemotherapy. A total of 11 (44%) patients were lost to follow-up during the course of treatment, of whom 3 died from metastatic disease. In 16 patients followed up for ≥ 3 months, complete tumor control was achieved in 11 (69%) patients, local tumor control in 14 (88%), and globe salvage in 7 (44%) at a mean follow-up of 25 months (median, 7 months; range, 3 to 110 months). No tumor recurrence was seen in any case. One (4%) serious adverse event of cardiotoxicity was noted. CONCLUSION: Platinum-based NACT is a suitable option for eSGC with advanced tumors and locoregional metastasis. Adverse events are rare and in patients compliant with treatment, NACT-based combination therapy offers globe salvage and systemic tumor control.
Subject(s)
Eyelid Neoplasms , Neoadjuvant Therapy , Sebaceous Gland Neoplasms , Humans , Middle Aged , Male , Female , Retrospective Studies , Eyelid Neoplasms/drug therapy , Eyelid Neoplasms/diagnosis , Eyelid Neoplasms/pathology , Sebaceous Gland Neoplasms/drug therapy , Sebaceous Gland Neoplasms/surgery , Sebaceous Gland Neoplasms/diagnosis , Sebaceous Gland Neoplasms/pathology , Neoadjuvant Therapy/methods , Aged , Adult , Adenocarcinoma, Sebaceous/drug therapy , Adenocarcinoma, Sebaceous/diagnosis , Adenocarcinoma, Sebaceous/pathology , Adenocarcinoma, Sebaceous/surgery , Follow-Up Studies , Cisplatin/administration & dosage , Cisplatin/therapeutic use , Aged, 80 and over , Fluorouracil/administration & dosage , Fluorouracil/therapeutic use , Chemotherapy, Adjuvant/methods , Carboplatin/administration & dosage , Carboplatin/therapeutic use , Neoplasm Staging , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Treatment OutcomeABSTRACT
BACKGROUND: Cutaneous squamous cell carcinoma (cSCC) frequently occurs in photoexposed areas. Surgery remains the mainstay of treatment in attempts to reduce recurrence, but it must be combined with other therapy because of the limited excision possible in the region of the eyelid, lip, and nose. Photodynamic therapy (PDT) is a relatively new treatment modality that involves the administration of a photosensitizing drug and its subsequent activation by specific wavelengths of light to produce reactive oxygen species that specifically destroy target cells. CASE REPORT: An 87-year-old female presented 4 weeks after initial resection with recurrent medium-differentiated cSCC measuring 5.2 cm × 3 cm × 2 cm in the left upper eyelid. Subsequent treatment involved palliative resection with an additional 1 cm at 3 margins of the tumor (excluding the bottom edge of the double eyelid line) and 3 applications of PDT using 5-aminolevulinic acid as the photosynthesizing agent in the open wound over a 2-week period. The wound healed well within 6 weeks. During the following 4 years, the patient showed satisfactory progress in both aesthetics and function, with no sign of recurrence or metastasis. CONCLUSION: Refractory cSCC was successfully managed using a combination of PDT and secondary healing, and functions of the head and face were well protected. These results suggest that such management warrants consideration in clinical settings.
Subject(s)
Aminolevulinic Acid , Carcinoma, Squamous Cell , Eyelid Neoplasms , Neoplasm Recurrence, Local , Photochemotherapy , Photosensitizing Agents , Humans , Female , Carcinoma, Squamous Cell/therapy , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/drug therapy , Photochemotherapy/methods , Aged, 80 and over , Eyelid Neoplasms/therapy , Eyelid Neoplasms/pathology , Eyelid Neoplasms/drug therapy , Treatment Outcome , Photosensitizing Agents/therapeutic use , Aminolevulinic Acid/therapeutic use , Skin Neoplasms/therapy , Skin Neoplasms/pathology , Skin Neoplasms/drug therapy , Combined Modality Therapy , Wound Healing/drug effectsABSTRACT
BACKGROUND: In oculoplastic surgery, reconstruction of a large defect after the removal of a massive malignant lower lid tumor still represents a unique challenge. We will report on this case, including a presentation of the case using step ladder V-Y advancement flap. METHODS: During November 2018 to March 2023, five patients of lower eyelid malignant tumor had wide resection with safety margin and reconstructed using step ladder V-Y advancement flap. The flap was used step ladder V-Y advancement flap. RESULTS: No complications, including ectropion deformity, occurred. This flap does not sacrifice healthy skin as seen with the cheek rotation flap, and the area of dissection is very small and can be performed in a short time. CONCLUSIONS: Step ladder V-Y advancement flap is highly useful in cases that require a reconstruction of a large defect after the removal of a massive malignant lower lid tumor from viewpoints of operating time, ease of procedure, aesthetics, and complications.
Subject(s)
Blepharoplasty , Eyelid Neoplasms , Eyelids , Plastic Surgery Procedures , Surgical Flaps , Humans , Eyelid Neoplasms/surgery , Male , Aged , Blepharoplasty/methods , Female , Eyelids/surgery , Middle Aged , Plastic Surgery Procedures/methods , Aged, 80 and over , Carcinoma, Basal Cell/surgeryABSTRACT
INTRODUCTION: Sebaceous gland carcinoma (SGC) of the eyelid is an aggressive tumour with the ability to metastasise and an increased morbidity. Controversies regarding the epidemiology of this malignant eyelid tumour is widespread in the scientific literature. Western reports repeatedly describes eyelid SGC as a rare occurring tumour in general, accounting for 1%-3% of all eyelid tumours, however studies from Asia have uncovered a higher frequency of eyelid SGC including 54% of all eyelid tumours in Japan, and 43%-56% in India. We wish to retrieve observational data of eyelid SGC prevalence in proportion to total eyelid tumours, from pathological studies published worldwide to resolve this controversy. METHODS AND ANALYSIS: We will search Ovid Medline, EMBASE, Cochrane Central Register of Controlled Trials, Scopus and Google Scholar to identify published reports on eyelid SGC prevalence proportions, aiming to clarify the incidence of the tumour. We will include observational clinicopathological studies reporting prevalence with confirmed histopathology. No limitations on publication date or language will be applied. Data from the individual studies and study quality will be extracted by two individual reviewers. Study quality will be assessed using the JBI Critical Appraisal Instrument for Studies Reporting Prevalence Data. Raw proportions will be transformed and pooled using a random effects model for meta-analysis. And subgroup analysis according to geography will be performed. If data are deemed unsuitable for a meta-analysis, a narrative synthesis will be presented. We will judge the certainty of evidence and present whether this has an overall effect on the results. The results may shed light on a long-standing academic disparity of the scientific literature. ETHICS AND DISSEMINATION: This systematic review does not require ethical approval. The results of this proposed review will be the subject to a publication in an international peer-reviewed journal within the ophthalmic or pathological specialty. PROSPERO REGISTRATION NUMBER: CRD42023487141.
Subject(s)
Eyelid Neoplasms , Meta-Analysis as Topic , Research Design , Sebaceous Gland Neoplasms , Systematic Reviews as Topic , Humans , Eyelid Neoplasms/epidemiology , Eyelid Neoplasms/pathology , Prevalence , Sebaceous Gland Neoplasms/pathology , Sebaceous Gland Neoplasms/epidemiology , Adenocarcinoma, Sebaceous/epidemiology , Adenocarcinoma, Sebaceous/pathologyABSTRACT
A man aged 73 years presented with a 5-day history of a fast-growing right eyebrow nodule with raised borders and central ulceration. There was no discomfort, and the patient denied vision changes. The lesion was refractory to treatment with erythromycin, clindamycin, and trimethoprim/sulfamethoxazole. What would you do next?
Subject(s)
Eyelid Neoplasms , Humans , Male , Aged , Eyelid Neoplasms/diagnosis , Eyelid Neoplasms/pathology , Eyelid Diseases/diagnosis , Diagnosis, Differential , Eyelids/pathologyABSTRACT
Approximately 5-15% of all dermatologic malignancies manifest in the upper and lower eyelids. The primary types include basal cell carcinoma, squamous cell carcinoma, and sebaceous cell carcinoma, with Merkel cell carcinoma and melanoma following closely behind. Basal cell carcinoma predominantly affects the lower eyelid, yet various other carcinomas, melanomas, metastases, and neoplasms of diverse origins can arise on both upper and lower eyelids. Risk factors such as advanced age, smoking, and notably, exposure to UV light significantly contribute to the development of these eyelid lesions. Despite the increasing incidence, research on dermatologic eyelid malignancies remains limited. However, such study is imperative given that many systemic oncologic malignancies initially present as metastatic eyelid lesions. This paper provides an in-depth exploration of eyelid anatomy, clinical presentation, diagnosis, and treatment management.Key Points: Eyelid metastases represent less than one percent of all eyelid cancers, yet they often serve as the initial indication of an underlying systemic malignancy. Early detection and treatment is crucial in improving prognosis and quality of life for patients. Treatment options encompass a range of modalities, with Mohs surgery as the gold standard for the removal of ocular tumors. Additional treatment options include local excision as well as non-surgical interventions such as radiotherapy, cryotherapy, immunotherapy, and topical medications.
Subject(s)
Eyelid Neoplasms , Humans , Eyelid Neoplasms/therapy , Eyelid Neoplasms/diagnosis , Eyelid Neoplasms/epidemiology , Eyelid Neoplasms/pathology , Eyelids/pathology , Mohs Surgery , Skin Neoplasms/therapy , Skin Neoplasms/diagnosis , Skin Neoplasms/pathology , Skin Neoplasms/epidemiology , Melanoma/therapy , Melanoma/diagnosis , Melanoma/pathology , Melanoma/epidemiology , Carcinoma, Merkel Cell/therapy , Carcinoma, Merkel Cell/diagnosis , Carcinoma, Merkel Cell/epidemiology , Carcinoma, Merkel Cell/secondary , Carcinoma, Merkel Cell/pathology , Risk Factors , Carcinoma, Basal Cell/therapy , Carcinoma, Basal Cell/diagnosis , Carcinoma, Basal Cell/epidemiology , Carcinoma, Basal Cell/pathology , Carcinoma, Basal Cell/secondary , Quality of Life , Carcinoma, Squamous Cell/therapy , Carcinoma, Squamous Cell/diagnosis , Carcinoma, Squamous Cell/secondary , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/epidemiology , Sebaceous Gland Neoplasms/therapy , Sebaceous Gland Neoplasms/diagnosis , Sebaceous Gland Neoplasms/pathologyABSTRACT
Orbital and periocular metastatic tumors used to be considered very rare; however, with the constant updating of drugs and detection methods for cancer treatment, new chemotherapies and radiation treatments are being used. The life expectancy of cancer patients has become longer and periocular metastases are becoming easier to detect. Our knowledge of this rare disease of metastases also needs to be updated. This article reviews the incidence, symptomatic presentation, clinical features, diagnostic approaches and current treatment of metastatic tumors of the orbit and ocular adnexa in these patients.
Subject(s)
Orbital Neoplasms , Humans , Orbital Neoplasms/secondary , Orbital Neoplasms/therapy , Eyelid Neoplasms/therapy , Eyelid Neoplasms/pathology , Eyelid Neoplasms/epidemiology , Eyelid Neoplasms/secondary , Eye Neoplasms/secondary , Eye Neoplasms/therapy , Eye Neoplasms/pathologyABSTRACT
BACKGROUND: Subtotal and total lower eyelid tissue loss after tumour excision is a complex issue for reconstructive surgeons. The anterior and posterior flaps must be restored to avoid compromising the functional and aesthetic prognosis of the eye. This study used a septal chondromucosal graft for the posterior lamella and a fasciocutaneous flap pedicled on the temporal artery for the anterior lamella. METHOD: We conducted a 10-year monocentric retrospective study, including 18 patients who were treated using a septal chondromucosal graft with a temporal artery pedicle flap following tumour excision. We collected demographic and medico-surgical data related to flap survival, absence of ectropion, lagophthalmos and other post-operative complications. The aesthetic outcome was judged using a grading scale during the last follow-up consultation. RESULTS: All grafts and flaps survived, whereas 2 patients required early repeat surgery (1 for ectropion and 1 for graft site haematoma). None of the patients developed lagophthalmos. Two patients had distal flap injuries that healed with local care. All patients were satisfied with the aesthetic outcome at the last follow-up visit. CONCLUSION: Combining a septal chondromucosal graft with a fasciocutaneous flap pedicled to the temporal artery for total lower eyelid reconstruction is a reliable method with satisfactory functional and cosmetic outcomes.
Subject(s)
Eyelid Neoplasms , Surgical Flaps , Temporal Arteries , Humans , Male , Female , Surgical Flaps/blood supply , Retrospective Studies , Aged , Middle Aged , Temporal Arteries/transplantation , Temporal Arteries/surgery , Eyelid Neoplasms/surgery , Eyelids/surgery , Aged, 80 and over , Graft Survival , Plastic Surgery Procedures/methods , Adult , Blepharoplasty/methods , Treatment Outcome , Carcinoma, Basal Cell/surgery , Esthetics , Nasal Cartilages/transplantation , Nasal Cartilages/surgeryABSTRACT
A 6-year-old male golden retriever presented with swelling of the left upper eyelid of 2 months duration, which did not improve following a course of antibiotics. Routine serum biochemistry, complete blood count and diagnostic imaging identified no clinically significant abnormalities. The mass was surgically excised, and histopathologic examination was performed. Eosinophilic granulocytic sarcoma (GS) was diagnosed based on the results of histopathology and immunohistochemistry. This is the first report of GS affecting the eyelid of a dog.
Subject(s)
Dog Diseases , Sarcoma, Myeloid , Animals , Dogs , Male , Dog Diseases/surgery , Dog Diseases/diagnosis , Dog Diseases/pathology , Sarcoma, Myeloid/veterinary , Sarcoma, Myeloid/diagnosis , Sarcoma, Myeloid/pathology , Sarcoma, Myeloid/surgery , Eyelid Neoplasms/veterinary , Eyelid Neoplasms/surgery , Eyelid Neoplasms/diagnosis , Eyelid Neoplasms/pathologyABSTRACT
Merkel cell carcinoma (MCC) is an unusual skin tumor that has a significant rate of distant and local metastases. It is known that primary MCC of the eyelid usually occurs at the upper eyelid. Here we report an unusual case of MCC metastasis to the eyelid. A 63-year-old male was diagnosed with MCC three years earlier after initially presenting with a mass in his right thigh. After histopathological diagnosis, the patient received medical therapy. During treatment, he developed multiple distant metastases and a firm, purple, vascularized lesion on the upper eyelid. We confirmed the lesion was an eyelid metastasis of MCC by histopathological examination and imaging methods. This case shows that extraocular MCC can metastasize to the eyelids, particularly the upper eyelid, where primary periocular MCC usually appears.
Subject(s)
Carcinoma, Merkel Cell , Eyelid Neoplasms , Skin Neoplasms , Humans , Male , Carcinoma, Merkel Cell/secondary , Carcinoma, Merkel Cell/diagnosis , Middle Aged , Eyelid Neoplasms/secondary , Eyelid Neoplasms/diagnosis , Skin Neoplasms/secondary , Skin Neoplasms/diagnosis , Skin Neoplasms/pathology , Biopsy , Eyelids/pathologyABSTRACT
PURPOSE: The aim of this article is to describe a new reconstructive technique of the lower eyelid in the surgery of tumors involving the medial canthal tendon. METHODS: Our new technique consists of detaching and reflecting the most medial portion of the anterior medial canthal tendon and reinserting it into the posterior lamella. We describe the cases in which our technique can be useful, as well as the results we have obtained. RESULTS: The result after a year of follow-up showed no disruption of the angulation of the lower eyelid line and no changes in eyelid position. CONCLUSIONS: The medial canthal tendon reflection could provide both aesthetic and functional results that may be superior to the usual techniques.
Subject(s)
Blepharoplasty , Eyelid Neoplasms , Eyelids , Tendons , Humans , Eyelid Neoplasms/surgery , Tendons/surgery , Blepharoplasty/methods , Eyelids/surgery , Male , Female , Aged , Middle Aged , Plastic Surgery Procedures/methodsSubject(s)
Eyelid Neoplasms , Sebaceous Gland Neoplasms , Female , Humans , Male , Middle Aged , Adenocarcinoma, Sebaceous/diagnosis , Adenocarcinoma, Sebaceous/chemically induced , Adenocarcinoma, Sebaceous/drug therapy , Eyelid Neoplasms/drug therapy , Eyelid Neoplasms/diagnosis , Sebaceous Gland Neoplasms/diagnosis , Sebaceous Gland Neoplasms/chemically induced , Sebaceous Gland Neoplasms/drug therapy , AdultABSTRACT
INTRODUCTION: The eyelids are a common site for skin tumours and account for 5-10% of all skin tumours. Treatment is mainly surgical and aims to preserve the anatomical structure of the eyelid, its function and not least its aesthetic appearance. AIM: Presentation of recurrence and complication rates of tumour-related eyelid surgery in a cohort of 450 tumours. RESULTS: Analysis of a cohort of 450 tumours operated on revealed 13 (2.8%) operations with recurrences and 32 (7%) with complications. The statistical significance of recurrences was observed for the involved and uninvolved ciliary margin. At the temporal canthus, 23.1% of recurrences occurred compared to 7.7% at the medial canthus. SGC has the highest recurrence rate. Complications include the following: ectropion, dehiscence, gross cicatrix with normal function, retraction, post-radiation damage, sub-graft haemorrhage and graft rejection. CONCLUSIONS: The recurrence rate of eyelid tumours is lower than that of complications. The choice of surgical technique determines the frequency of complications and histological control of the excised tissue, as well as the frequency of recurrences.
Subject(s)
Eyelid Neoplasms , Neoplasm Recurrence, Local , Plastic Surgery Procedures , Humans , Eyelid Neoplasms/surgery , Female , Male , Plastic Surgery Procedures/methods , Middle Aged , Aged , Postoperative Complications/etiology , Adult , Aged, 80 and over , Eyelids/surgeryABSTRACT
In this review, we aim to provide an overview of the five most common malignant eyelid tumors with current treatment recommendations based on international guidelines. Particular attention is paid to the clinicopathological correlation and the update with regard to adequate treatment. Newer systemic therapies enrich the existing treatment options, of which complete tumor excision remains the most important therapeutic measure.
Subject(s)
Eyelid Neoplasms , Humans , Eyelid Neoplasms/therapy , Eyelid Neoplasms/pathologyABSTRACT
BACKGROUND: Mohs surgery of eyelid skin cancers requires detailed knowledge of anatomy for precise surgery and accurate evaluation of histology. OBJECTIVE: To review the histology of the peritarsal eyelid using frozen sections as encountered intraoperatively by Mohs surgeons. METHODS: The authors review the literature describing the anatomy and histology of the peritarsal eyelid from the lens of a Mohs surgeon. Histology from select Mohs cases is used to frame the discussion of the microanatomy of this region. RESULTS: The peritarsal eyelids contain a unique mixture of skin, muscle, tarsus, glandular tissue, and conjunctiva. The histologic appearance of many of these structures differs from skin found outside of this anatomic region. Tumors of the eyelid and periocular region may mimic normal histologic structures found within the peritarsal eyelid. CONCLUSION: The peritarsal eyelids have unique anatomy and associated histologic structures. Knowledge of the detailed histoanatomy is required for confident execution of Mohs surgery in this anatomic region.